Your browser doesn't support javascript.
loading
Reversal of Drug Resistance in K562/ADM Cells Caused by RA and the Related Mechanisms / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1704-1709, 2021.
Article de Zh | WPRIM | ID: wpr-922321
Bibliothèque responsable: WPRO
ABSTRACT
OBJECTIVE@#To investigate the effect of ursane triterpenoids 3β,19α-dihydroxyursu-12-ene-23,28-dicarboxylic acid (Rotundioic acid, RA) on the sensitivity of adriamycin-resistant K562 cells (K562/ADM Cell) anti-tumor drug, and to explore the effect and mechanism of RA on the multidrug resistance of K562/ADM cells.@*METHODS@#CCK-8 method was used to detect the effect of RA on the sensitivity of K562 cells and K562/ADM cells to anti-tumor drug. Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were used to detect the expression level of mRNA and the protein in K562 and K562/ADM cells, and the effect of RA on the expression of MDR1 mRNA and P-gp in K562/ADM cells was also detected; Western blot was used to detect the expression of p-JNK, p-p38 and p-ERK1/2 in K562/ADM cells.@*RESULTS@#RA could increased the sensitivity of K562/ADM cells to adriamycin(the reversal factor was 1.61 times), the difference showed statistically significantly (P<0.05); the resistance factor of K562/ADM to ADM was 41.76 times. The expression of MDR1 mRNA in K562 cells was extremely low, and the protein product P-glycoprotein (P-gp) was almost not expressed; MDR1 mRNA and P-gp in K562/ADM cells were highly expressed; RA could down-regulate the expression levels of MDR1 and P-gp in K562/ADM cells. In addition, RA could upregulate the phosphorylation levels of p38 and ERK1/2 in K562/ADM cells, but it has no effect on the expression of p-JNK.@*CONCLUSION@#RA may participate in the regulation of MAPK signaling pathway by upregulating the expression levels of p-p38 and p-ERK1/2 in K562/ADM cells, and thus inhibit the transcription and translation levels of MDR1, and finally reverse the multidrug resistance of leukemia cells.
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Glycoprotéine P / Multirésistance aux médicaments / Résistance aux médicaments antinéoplasiques / Sous-famille B de transporteurs à cassette liant l'ATP / Cellules K562 Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2021 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Glycoprotéine P / Multirésistance aux médicaments / Résistance aux médicaments antinéoplasiques / Sous-famille B de transporteurs à cassette liant l'ATP / Cellules K562 Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2021 Type: Article